%0 Journal Article
%T Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first-line therapy for Chinese patients with metastatic renal cell carcinoma
%A Baijun Dong
%A Jin Zhang
%A Jiwei Huang
%A Lixin Zhou
%A Wei Xue
%A Wen Cai
%A Wen Kong
%A Yiran Huang
%A Yonghui Chen
%J Archive of "Cancer Communications".
%D 2017
%R 10.1186/s40880-017-0230-7
%X Baseline clinicopathologic and prognostic characteristics of 184 patients with metastatic renal cell carcinoma (mRCC
%K Metastatic renal cell carcinoma
%K Sorafenib
%K Sunitinib
%K Quality of life
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547674/